Early trial tests new drug duo to shrink tumors before surgery
NCT ID NCT06654297
Summary
This is a small, early-stage study to see if it is safe and practical to give two drugs together before surgery for a type of esophageal cancer. The drugs, camrelizumab and palbociclib, aim to help shrink the tumor and prepare it for removal. The main goal is to check for side effects and ensure the treatment doesn't delay the planned surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.